Re:Endonuclease fingerprint indicates a synthetic origin of ...
by ishche on Thursday October 20, 2022 @04:24PM
(#33280185)
Isn't it enough infections already to sell tons of drugs, why to design the new for this case?
[ Parent
| on HN ]
Re:Endonuclease fingerprint indicates a synthetic origin of ...
by Ancapistani on Thursday October 20, 2022 @04:54PM
(#33280552)
Well, if you own the patent on the only approved drug for the condition, it would make financial sense.
NOTE: I am emphatically not asserting that this is the case with SARS-CoV-2. I am only responding to the parent comment's criticism of a possible financial motive for hypothetical biotech companies to purposefully engineer pathogens for profit.